These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10527675)

  • 61. Autosomal dominant polycystic kidney disease: cellular and molecular mechanisms of cyst formation.
    Wilson PD; Burrow CR
    Adv Nephrol Necker Hosp; 1992; 21():125-42. PubMed ID: 1566642
    [No Abstract]   [Full Text] [Related]  

  • 62. Transepithelial chloride secretion and cystogenesis in autosomal dominant polycystic kidney disease.
    Persu A; Devuyst O
    Nephrol Dial Transplant; 2000 Jun; 15(6):747-50. PubMed ID: 10831619
    [No Abstract]   [Full Text] [Related]  

  • 63. Inherited autosomal dominant polycystic kidney disease--genetic polymorphism.
    Karnolski IN
    Folia Med (Plovdiv); 2002; 44(4):7-9. PubMed ID: 12751680
    [No Abstract]   [Full Text] [Related]  

  • 64. Renal disease. II. The polycystic kidney disease 1 (PKD-1) gene: an important clue in the study of renal cyst formation.
    Ong AC
    J R Coll Physicians Lond; 1997; 31(2):141-6. PubMed ID: 9131510
    [No Abstract]   [Full Text] [Related]  

  • 65. Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat.
    Brown JH; Bihoreau MT; Hoffmann S; Kränzlin B; Tychinskaya I; Obermüller N; Podlich D; Boehn SN; Kaisaki PJ; Megel N; Danoy P; Copley RR; Broxholme J; Witzgall R; Lathrop M; Gretz N; Gauguier D
    J Am Soc Nephrol; 2005 Dec; 16(12):3517-26. PubMed ID: 16207829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Current viewpoints in the development of cystic kidneys in adults].
    Hené RJ; Koomans HA; Monnens LA
    Ned Tijdschr Geneeskd; 1992 Feb; 136(6):269-73. PubMed ID: 1741069
    [No Abstract]   [Full Text] [Related]  

  • 67. The molecular biology of polycystic kidney disease.
    Murcia NS; Woychik RP; Avner ED
    Pediatr Nephrol; 1998 Nov; 12(9):721-6. PubMed ID: 9874315
    [TBL] [Abstract][Full Text] [Related]  

  • 68. What is the role of somatic mutation in autosomal dominant polycystic kidney disease?
    Harris PC
    J Am Soc Nephrol; 2010 Jul; 21(7):1073-6. PubMed ID: 20488953
    [No Abstract]   [Full Text] [Related]  

  • 69. Polycystic kidney disease: In danger of being X-rated?
    Grantham JJ; Calvet JP
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):790-2. PubMed ID: 11158545
    [No Abstract]   [Full Text] [Related]  

  • 70. Identification of a new target molecule for a cascade therapy of polycystic kidney.
    Yoshida N; Yano Y; Yoshiki A; Ueno M; Deguchi N; Hirotsune S
    Hum Cell; 2003 Jun; 16(2):65-72. PubMed ID: 12968785
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease.
    Ma M; Tian X; Igarashi P; Pazour GJ; Somlo S
    Nat Genet; 2013 Sep; 45(9):1004-12. PubMed ID: 23892607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Advances in polycystic kidney disease.
    Schneider MC
    Mol Med Today; 1996 Feb; 2(2):70-5. PubMed ID: 8796859
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Autosomal dominant polycystic kidney disease.
    Torres VE; Harris PC
    Nefrologia; 2003; 23 Suppl 1():14-22. PubMed ID: 12708359
    [No Abstract]   [Full Text] [Related]  

  • 74. PKD3-to be or not to be?
    Paterson AD; Pei Y
    Nephrol Dial Transplant; 1999 Dec; 14(12):2965-6. PubMed ID: 10570111
    [No Abstract]   [Full Text] [Related]  

  • 75. Phenotype recognition. Clinicians' contributions to molecular genetics.
    Gardner KD
    West J Med; 1992 May; 156(5):491-4. PubMed ID: 1595272
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combined cystic disease of the liver and kidney.
    D'Agata ID; Jonas MM; Perez-Atayde AR; Guay-Woodford LM
    Semin Liver Dis; 1994 Aug; 14(3):215-28. PubMed ID: 7939783
    [No Abstract]   [Full Text] [Related]  

  • 77. [New strategy for the treatment of autosomal dominant polycystic kidney disease].
    Horie S
    Nihon Jinzo Gakkai Shi; 2015; 57(1):254-61. PubMed ID: 25735085
    [No Abstract]   [Full Text] [Related]  

  • 78. Phenotypic variability in PKD1: the family as a starting point.
    Guay-Woodford LM
    Kidney Int; 1999 Jul; 56(1):344-6. PubMed ID: 10411712
    [No Abstract]   [Full Text] [Related]  

  • 79. Mutations and intragenic polymorphisms in the diagnosis of autosomal dominant polycystic kidney disease type 1.
    Badenas C; Torra R; Darnell A; Estivill X
    Contrib Nephrol; 1997; 122():45-8. PubMed ID: 9399037
    [No Abstract]   [Full Text] [Related]  

  • 80. Autosomal dominant polycystic kidney disease: a two-hit model.
    Germino GG
    Hosp Pract (1995); 1997 Mar; 32(3):81-2, 85-8, 91-2 passim. PubMed ID: 9078975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.